$EKF

EKF Diagnostics Holdings plc reported its Q4 results for 2025, showcasing substantial growth in revenues and profit margins. The company's expansion into new markets and continued demand for its diagnostic products were highlighted positively in the earnings call. However, concerns regarding increased competition and supply chain challenges were raised. Management provided optimistic guidance for the upcoming quarters, asserting their position in the market. Overall, the results indicate a strong performance despite facing some operational hurdles.